Sonia Pernas

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Venues

Cancers

Therapeutic advances in medical oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

INSTITUT CATALA D'ONCOLOGIA

This page only lists publications with an associated author ORCID identifier.

Affiliation History

INSTITUT CATALA D'ONCOLOGIA Nov 02 2004

Spain

Medical Oncologist, Head of the Breast Cancer Unit :: MEDICAL ONCOLOGY-BREAST UNIT

Publications

Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Adrienne G Waks, Juan Miguel Cejalvo, Mireia Margelí, Pablo Tolosa, Francisco Javier Salvador-Bofill, Josefina Cruz, Blanca González-Farré, Esther Sanfeliu, Andreu Òdena, Violeta Serra, Francisco J Pardo-Palacios, Ana María Luna Barrera, Miriam Arumi, Juan Antonio Guerra, Guillermo Villacampa, Rodrigo Sánchez-Bayona, Eva Ciruelos, Martín Espinosa-Bravo, Yann Izarzugaza, Patricia Galván, Judith Matito, Sonia Pernas, María Jesús Vidal Losada, Anu Santhanagopal, Dalila Sellami, Stephen Esker, Pang-Dian Fan, Fumitaka Suto, Ana Vivancos, Tomás Pascual, Aleix Prat, Mafalda Oliveira
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response. Nature communications 15 (1) (2024)
Aditya Bardia, Komal L Jhaveri, Seock-Ah Im, Sonia Pernas, Michelino De Laurentiis, Shu-Sen Wang, Noelia Martínez Jañez, Giuliano Borges, David W Cescon, Masaya Hattori, Yen-Shen Lu, Erika Paige Hamilton, Qingyuan Zhang, Junji Tsurutani, Kevin M Kalinsky, Pedro Emanuel Rubini Liedke, Lu Xu, Rick M Fairhurst, Sabrina Khan, Neelima Denduluri, Hope S Rugo, Binghe Xu, Barbara Pistilli, null null
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Miguel Quintela-Fandino, Begoña Bermejo, Esther Zamora Adelantado, Fernando Moreno Antón, José Angel García-Saenz, Sonia Pernas, Noelia Martínez Jáñez, Desirée Jiménez, Encarna Adrover, R Andrés Conejero, Silvana Mourón, Maria Jose Bueno, Luis Manso Sanchez, Gemma Viñas, Emilio Alba, Antonio Llombart, Javier Cortes, Cristina Tebar, Denise J Roe, Adam Grant, Adam W Watson, Ramón Colomer, Ghassan Mouneimne
High mechanical conditioning by tumor extracellular matrix stiffness is a predictive biomarker for anti-fibrotic therapy in HER2-negative breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Catalina Falo, Juan Azcarate, Sergi Fernandez-Gonzalez, Xavier Perez, Ana Petit, Héctor Pérez-Montero, Andrea Vethencourt, Silvia Vazquez, Maria Laplana, Miriam Ales, Agostina Stradella, Bartomeu Fullana, Maria Jesús Pla-Farnós, Anna Gumà, Raul Ortega, Mar Varela, Diana Pérez, Jose Luis Ponton, Sara Cobo, Ana Benitez, Miriam Campos, Adela Fernández, Rafael Villanueva, Veronica Obadia, Sabela Recalde, Teresa Soler-Monsó, Ana Lopez-Ojeda, Evelyn Martinez, Jordi Ponce Sebastià, Sonia Pernas, Juan Miguel Gil-Gil, Amparo Garcia-Tejedor
Breast Cancer Patient's Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II-III Disease. Cancers 16 (13) (2024)
Catalina Falo, Juan Azcarate, Sergi Fernandez-Gonzalez, Xavier Perez, Ana Petit, Héctor Pérez-Montero, Andrea Vethencourt, Silvia Vazquez, Maria Laplana, Miriam Ales, Agostina Stradella, Bartomeu Fullana, Maria Jesús Pla-Farnós, Anna Gumà, Raul Ortega, Mar Varela, Diana Pérez, Jose Luis Ponton, Sara Cobo, Ana Benitez, Miriam Campos, Adela Fernández, Rafael Villanueva, Veronica Obadia, Sabela Recalde, Teresa Soler-Monsó, Ana Lopez-Ojeda, Evelyn Martinez, Jordi Ponce Sebastià, Sonia Pernas, Juan Miguel Gil-Gil, Amparo Garcia-Tejedor
Breast Cancer Patient's Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II-III Disease. Cancers 16 (13) (2024)
Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Adrienne G Waks, Juan Miguel Cejalvo, Mireia Margelí, Pablo Tolosa, Francisco Javier Salvador-Bofill, Josefina Cruz, Blanca González-Farré, Esther Sanfeliu, Andreu Òdena, Violeta Serra, Francisco J Pardo-Palacios, Ana María Luna Barrera, Miriam Arumi, Juan Antonio Guerra, Guillermo Villacampa, Rodrigo Sánchez-Bayona, Eva Ciruelos, Martín Espinosa-Bravo, Yann Izarzugaza, Patricia Galván, Judith Matito, Sonia Pernas, María Jesús Vidal Losada, Anu Santhanagopal, Dalila Sellami, Stephen Esker, Pang-Dian Fan, Fumitaka Suto, Ana Vivancos, Tomás Pascual, Aleix Prat, Mafalda Oliveira
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response. Nature communications 15 (1) (2024)
Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Adrienne G Waks, Juan Miguel Cejalvo, Mireia Margelí, Pablo Tolosa, Francisco Javier Salvador-Bofill, Josefina Cruz, Blanca González-Farré, Esther Sanfeliu, Andreu Òdena, Violeta Serra, Francisco J Pardo-Palacios, Ana María Luna Barrera, Miriam Arumi, Juan Antonio Guerra, Guillermo Villacampa, Rodrigo Sánchez-Bayona, Eva Ciruelos, Martín Espinosa-Bravo, Yann Izarzugaza, Patricia Galván, Judith Matito, Sonia Pernas, María Jesús Vidal Losada, Anu Santhanagopal, Dalila Sellami, Stephen Esker, Pang-Dian Fan, Fumitaka Suto, Ana Vivancos, Tomás Pascual, Aleix Prat, Mafalda Oliveira
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response. Nature communications 15 (1) (2024)
Héctor Pérez-Montero, Alicia Lozano, Rodolfo de Blas, Juan José Sánchez, Evelyn Martínez, Maria Laplana, Juan Miguel Gil-Gil, Amparo Garcia-Tejedor, Sonia Pernas, Catalina Falo, Oscar Godino, Maria Jesús Pla-Farnós, Ferran Guedea, Arturo Navarro-Martin
Ten-year experience of bone SBRT in breast cancer: analysis of predictive factors of effectiveness. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Amparo Garcia-Tejedor, Catalina Falo, Sergi Fernandez-Gonzalez, Maria Laplana, Miguel Gil-Gil, Teresa Soler-Monso, Evelyn Martinez-Perez, Iris Calvo, Hugo Calpelo, Maria-Teresa Bajen, Ana Benitez, Raul Ortega, Anna Petit, Anna Guma, Miriam Campos, Agostina Stradella, Ana Lopez-Ojeda, Jordi Ponce, Maria J Pla, Sonia Pernas
Management of the axilla in postmenopausal patients with cN0 hormone receptor-positive/HER2-negative breast cancer treated with neoadjuvant endocrine therapy and its prognostic impact. Breast cancer research and treatment (2023)
José Angel García-Saenz, Isabel Blancas, Isabel Echavarría, Carmen Hinojo, Mireia Margeli, Fernando Moreno Antón, Sonia Pernas, Teresa Ramon Y Cajal, Nuria Ribelles, Meritxell Bellet
SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Alexandra Pons-Riverola, Herminio Morillas, Javier Berdejo, Sonia Pernas, Helena Pomares, Leyre Asiain, Alberto Garay, Adela Fernandez-Ortega, Ana Carla Oliveira, Evelyn Martínez, Santiago Jiménez-Marrero, Elena Pina, Eduard Fort, Raúl Ramos, Lídia Alcoberro, Encarnación Hidalgo, Maite Antonio-Rebollo, Laia Alcober, Cristina Enjuanes Grau, Josep Comín-Colet, Pedro Moliner Borja
Developing Cardio-Oncology Programs in the New Era: Beyond Ventricular Dysfunction Due to Cancer Treatments. Cancers 15 (24) (2023)
Alexandra Pons-Riverola, Herminio Morillas, Javier Berdejo, Sonia Pernas, Helena Pomares, Leyre Asiain, Alberto Garay, Adela Fernandez-Ortega, Ana Carla Oliveira, Evelyn Martínez, Santiago Jiménez-Marrero, Elena Pina, Eduard Fort, Raúl Ramos, Lídia Alcoberro, Encarnación Hidalgo, Maite Antonio-Rebollo, Laia Alcober, Cristina Enjuanes Grau, Josep Comín-Colet, Pedro Moliner Borja
Developing Cardio-Oncology Programs in the New Era: Beyond Ventricular Dysfunction Due to Cancer Treatments. Cancers 15 (24) (2023)
Aditya Bardia, Komal Jhaveri, Kevin Kalinsky, Sonia Pernas, Junji Tsurutani, Binghe Xu, Erika Hamilton, Seock-Ah Im, Zbigniew Nowecki, Joohyuk Sohn, Michelino De Laurentiis, Noelia Martínez Jañez, Barbara Adamo, Keun Seok Lee, Kyung Hae Jung, Gabor Rubovszky, Ling-Ming Tseng, Yen-Shen Lu, Yuan Yuan, Micah J Maxwell, Vincent Haddad, Sabrina S Khan, Hope S Rugo, Barbara Pistilli
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2- breast cancer. Future oncology (London, England) (2023)
José Angel García-Saenz, Isabel Blancas, Isabel Echavarría, Carmen Hinojo, Mireia Margeli, Fernando Moreno Antón, Sonia Pernas, Teresa Ramon Y Cajal, Nuria Ribelles, Meritxell Bellet
Correction to: SEOM-GEICAM-SOLTI clinical guidelines in advanced breast cancer (2022). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2023)
Sonia Pernas, Jennifer L Guerriero, Sergey Naumenko, Shom Goel, Meredith M Regan, Jiani Hu, Beth T Harrison, Filipa Lynce, Nancy U Lin, Ann Partridge, Aki Morikawa, John Hutchinson, Elizabeth A Mittendorf, Artem Sokolov, Beth Overmoyer
Early on-treatment transcriptional profiling as a tool for improving pathological response prediction in HER2-positive inflammatory breast cancer. Therapeutic advances in medical oncology 14 (2022)
Mónica Cejuela Solís, Begoña Martin-Castillo, Javier A Menendez, Sonia Pernas
Metformin and Breast Cancer: Where Are We Now? International journal of molecular sciences 23 (5) (2022)
Sonia Pernas, Sara M Tolaney
Clinical trial data and emerging strategies: HER2-positive breast cancer. Breast cancer research and treatment 193 (2) (2022)
Agostina Stradella, Pablo Gargallo, Mónica Cejuela, Anna Petit, Jan Bosch-Schips, Paula Carbonell, Sabela Recalde, Andrea Vethencourt, Adela Fernandez-Ortega, Catalina Falo, Juan Miguel Gil-Gil, Silvia Vázquez, Verónica Obadia, Rafael Villanueva-Vázquez, Teresa Soler-Monsó, Inés Calabria, Sonia Pernas
Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 35 (8) (2022)
Mónica Cejuela Solís, Andrea Vethencourt, Sonia Pernas
Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer. Current oncology reports 24 (12) (2022)
Laia Garrigós, Cristina Saura, Clara Martinez-Vila, Alberto Zambelli, Mark Bower, Barbara Pistilli, Matteo Lambertini, Diego Ottaviani, Nikolaos Diamantis, Ailsa Lumsden, Sonia Pernas, Daniele Generali, Elia Seguí, Gemma Viñas, Eudald Felip, Ana Sanchez, Gianpiero Rizzo, Armando Santoro, Alessio Cortellini, Ylenia Perone, John Chester, Maria Iglesias, Marta Betti, Bruno Vincenzi, Michela Libertini, Francesca Mazzoni, Federica Zoratto, Rossana Berardi, Annalisa Guida, Rachel Wuerstlein, Angela Loizidou, Rachel Sharkey, Juan Aguilar, Marta Matas, Chiara Saggia, Lorenzo Chiudinelli, Emeline Colomba-Blameble, Myria Galazi, Uma Mukherjee, Mieke Van Hemelrijck, Mar Marin, Carla Strina, Aleix Prat, Helena Pla, Eva Maria Ciruelos, Alexia Bertuzzi, Lucia Del Mastro, Giampiero Porzio, Thomas Newsom-Davis, Isabel Ruiz, Maria Belen Delany, Marco Krengli, Vittoria Fotia, Alessandro Viansone, Neha Chopra, Margarita Romeo, Ramon Salazar, Ignacio Perez, Francesca d'Avanzo, Michela Franchi, Manuela Milani, Fanny Pommeret, Marco Tucci, Paolo Pedrazzoli, Nadia Harbeck, Daniela Ferrante, David J Pinato, Alessandra Gennari
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry. Therapeutic advances in medical oncology 13 (2021)
Tomás Pascual, Aranzazu Fernandez-Martinez, Maki Tanioka, Maria Vittoria Dieci, Sonia Pernas, Joaquin Gavila, Valentina Guarnieri, Javier Cortes, Patricia Villagrasa, Núria Chic, María Jesús Vidal Losada, Barbara Adamo, Montserrat Muñoz, Gaia Griguolo, Antonio Llombart, PierFranco Conte, Mafalda Oliveira, Benedetta Conte, Laia Paré, Patricia Galvan, Lisa Anne Carey, Charles M Perou, Aleix Prat
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Milana A Bergamino, Sonia Pernas, Maggie Chon U Cheang
Lights and Shadows in Immuno-Oncology Drug Development. Cancers 13 (4) (2021)
Sonia Pernas, Sara M Tolaney
Management of Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. JCO oncology practice 17 (6) (2021)
Romualdo Barroso-Sousa, Tanya E Keenan, Sonia Pernas, Pedro Exman, Esha Jain, Ana Christina Garrido-Castro, Melissa Hughes, Brittany Bychkovsky, Renato Umeton, Janet L Files, Neal I Lindeman, Laura E MacConaill, F Stephen Hodi, Ian E Krop, Deborah Dillon, Eric P Winer, Nikhil Wagle, Nancy U Lin, Elizabeth A Mittendorf, Eliezer M Van Allen, Sara M Tolaney
Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Eva Ciruelos Gil, Patricia Villagrasa, Tomás Pascual, Mafalda Oliveira, Sonia Pernas, Laia Paré, Santiago Escriva-de-Romani, Luis Manso Sanchez, Barbara Adamo, E Martínez de Dueñas, Javier Cortes, Silvia Vazquez, Antonia Perelló, Isabel Garau, Mireia Melé, Alvaro Montaño, Begoña Bermejo, Serafin Morales Murillo, María J Echarri, Estela Vega, Blanca Gonzalez-Farre, Patricia Galván, Jordi Canes, Paolo G Nuciforo, Xavier Gonzalez, Aleix Prat
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Milana Bergamino Sirvén, Adela Fernández-Ortega, Agostina Stradella, Idoia Morilla, Catalina Falo, Silvia Vázquez, Roser Castany, Rafael Villanueva, Sabela Recalde, Valentí Navarro Pérez, Miguel Gil-Gil, Sonia Pernas
Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center. BMC pharmacology & toxicology 20 (1) (2019)
Sonia Pernas, Sara M Tolaney
HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance. Therapeutic advances in medical oncology 11 (2019)
Sonia Pernas, Sara M Tolaney, Eric P Winer, Shom Goel
CDK4/6 inhibition in breast cancer: current practice and future directions. Therapeutic advances in medical oncology 10 (2018)

Sonia Pernas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sonia Pernas